In summary, our study provides evidence that the increased expression of hepatic FGF21 in HFD-induced NAFLD promotes the progression of breast cancer by enhancing the anti-apoptotic abilities of breast cancer cells. The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatotic liver disease.